<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Dicoumarol</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00266</strong>&#160; (APRD00761)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00266/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00266/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00266.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00266.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00266.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00266.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00266.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00266">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>bis-3,3'-(4-hydroxycoumarinyl)methane</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>bis-hydroxycoumarin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>di-(4-hydroxy-3-coumarinyl)methane</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Dicumarol</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>USAN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anticoagulants">Anticoagulants</a></li>
<li><a href="/mesh/enzyme-inhibitors">Enzyme Inhibitors</a></li>
<li><a href="/mesh/uncoupling-agents">Uncoupling Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>66-76-2</td></tr><tr><th>Weight</th><td>Average: 336.295<br>Monoisotopic: 336.063388116</td></tr><tr><th>Chemical Formula</th><td>C<sub>19</sub>H<sub>12</sub>O<sub>6</sub></td></tr><tr><th>InChI Key</th><td>DOBMPNYZJYQDGZ-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one</div></td></tr><tr><th>SMILES</th><td><div class="wrap">OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00266.gif?1265922775">show</a>(9.73 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Phenylpropanoids and Polyketides</td></tr><tr><th>Class</th><td>Coumarins and Derivatives</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Coumarins and Derivatives</td></tr><tr><th>Alternative parents</th><td>Benzopyrans; Pyranones and Derivatives; Benzene and Substituted Derivatives; Polyamines</td></tr><tr><th>Substituents</th><td>pyranone; benzene; pyran; polyamine</td></tr><tr><th>Classification description</th><td>This compound belongs to the coumarins and derivatives. These are polycyclic aromatic compounds containing a 1-benzopyran moiety with a ketone group at the C2 carbon atom (1-benzopyran-2-one).</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For decreasing blood clotting. Often used along with heparin for treatment of deep vein thrombosis.</td></tr><tr><th>Pharmacodynamics</th><td>Dicumarol is an coumarin-like compound found in sweet clover. It is used as an oral anticoagulant and acts by inhibiting the hepatic synthesis of vitamin K-dependent coagulation factors (prothrombin and factors VII, IX, and X). It is also used in biochemical experiments as an inhibitor of reductases.</td></tr><tr><th>Mechanism of action</th><td>Dicumarol inhibits vitamin K reductase, resulting in depletion of the reduced form of vitamin K (vitamin KH2). As vitamin K is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins, this limits the gamma-carboxylation and subsequent activation of the vitamin K-dependent coagulant proteins. The synthesis of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Depression of three of the four vitamin K-dependent coagulation factors (factors II, VII, and X) results in decresed prothrombin levels and a decrease in the amount of thrombin generated and bound to fibrin. This reduces the thrombogenicity of clots.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub>=233 mg/kg (orally in mice); LD<sub>50</sub>=250 mg/kg (orally in rats)</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th><th>SMPDB ID</th></tr></thead><tbody><tr><td>Dicumarol Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00270?highlight%5Bcompounds%5D%5B%5D=DB00266&amp;highlight%5Bproteins%5D%5B%5D=DB00266">SMP00270</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.8724</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.8343</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.5899</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.5073</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9304</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8972</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8982</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8264</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.7557</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7905</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.8948</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9681</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.6071</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9098</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9165</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9048
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9549
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.8347
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          3.1251 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9269
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9435
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Eli lilly and co</li>
<li>Abbott laboratories pharmaceutical products div</li></ul></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>290 &#176;C</td><td>PhysProp</td></tr><tr><td>water solubility</td><td>128 mg/L</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>logP</td><td>2.07</td><td>HANSCH,C ET AL. (1995)</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>6.62e-02 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>1.54</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-1.6</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-3.7</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>-12</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>-3.1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>-1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>93.06</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>89.19</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>32.32</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Cullen JJ, Hinkhouse MM, Grady M, Gaut AW, Liu J, Zhang YP, Weydert CJ, Domann FE, Oberley LW: Dicumarol inhibition of <span class="caps">NADPH</span>:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res. 2003 Sep 1;63(17):5513-20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14500388">Pubmed</a></li>
	<li>Mironov AA, Colanzi A, Polishchuk RS, Beznoussenko GV, Mironov AA Jr, Fusella A, Di Tullio G, Silletta MG, Corda D, De Matteis MA, Luini A: Dicumarol, an inhibitor of <span class="caps">ADP</span>-ribosylation of CtBP3/<span class="caps">BARS</span>, fragments golgi non-compact tubular zones and inhibits intra-golgi transport. Eur J Cell Biol. 2004 Jul;83(6):263-79. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15511084">Pubmed</a></li>
	<li>Abdelmohsen K, Stuhlmann D, Daubrawa F, Klotz LO: Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication. Arch Biochem Biophys. 2005 Feb 15;434(2):241-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15639223">Pubmed</a></li>
	<li>Thanos CG, Liu Z, Reineke J, Edwards E, Mathiowitz E: Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride. Pharm Res. 2003 Jul;20(7):1093-100. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12880296">Pubmed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D03798" target="_blank">D03798 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C00796" target="_blank">C00796 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>BindingDB</td><td><a class="wishart-link-out" href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35525" target="_blank">35525 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=4513" target="_blank">4513 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1466" target="_blank">CHEMBL1466 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000768" target="_blank">DAP000768 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA449298" target="_blank">PA449298 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Dicumarol" target="_blank">Dicumarol <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>B01AA01<ul class="atc-drug-tree"><li><a href="/atc/B#B">B &#8212; BLOOD AND BLOOD FORMING ORGANS</a></li><li><a href="/atc/B01#B01">B01 &#8212; ANTITHROMBOTIC AGENTS</a></li><li><a href="/atc/B01A#B01A">B01A &#8212; ANTITHROMBOTIC AGENTS</a></li><li><a href="/atc/B01AA#B01AA">B01AA &#8212; Vitamin K antagonists</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00266.pdf?1265922737">show</a>(64.7 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00316">Acetaminophen</a></td><td>Acetaminophen may increase the anticoagulant effect of dicumarol. Monitor for changes in the therapeutic and adverse effects of dicumarol if acetaminophen is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00414">Acetohexamide</a></td><td>Dicumarol may increase the effect of sulfonylurea, acetohexamide.</td></tr><tr><td><a href="/drugs/DB00945">Acetylsalicylic acid</a></td><td>Acetylsalicylic acid increases effect of the anticoagulant, dicumarol.</td></tr><tr><td><a href="/drugs/DB00437">Allopurinol</a></td><td>Allopurinol may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00357">Aminoglutethimide</a></td><td>Aminoglutethimide may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01118">Amiodarone</a></td><td>Amiodarone may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00701">Amprenavir</a></td><td>Amprenavir may increase the anticoagulant effect of dicumarol by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB00673">Aprepitant</a></td><td>Aprepitant may decrease the anticoagulant effect of dicumarol by decreasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB01072">Atazanavir</a></td><td>The protease inhibitor, atazanavir, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00993">Azathioprine</a></td><td>Azathioprine may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00207">Azithromycin</a></td><td>Azithromycin may increase the anticoagulant effect of dicumarol by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB00443">Betamethasone</a></td><td>The corticosteroid, betamethasone, alters the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00559">Bosentan</a></td><td>Bosentan may decrease the anticoagulant effect of dicumarol by increasing its metabolism.</td></tr><tr><td><a href="/drugs/DB01101">Capecitabine</a></td><td>Capecitabine may increase the anticoagulant effect of dicumarol by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the anticoagulant effect of dicumarol by decreasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB01330">Cefotetan</a></td><td>The cephalosporin, cefotetan, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01331">Cefoxitin</a></td><td>The cephalosporin, cefoxitin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01212">Ceftriaxone</a></td><td>The cephalosporin, ceftriaxone, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00482">Celecoxib</a></td><td>Celecoxib may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00672">Chlorpropamide</a></td><td>Dicumarol may increase the effect of sulfonylurea, chlorpropamide.</td></tr><tr><td><a href="/drugs/DB01432">Cholestyramine</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of dicumarol by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Cimetidine may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>The quinolone antibiotic, ciprofloxacin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00604">Cisapride</a></td><td>Cisapride may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00215">Citalopram</a></td><td>The SSRI, citalopram, increases the effect of anticoagulant, dicumarol.</td></tr><tr><td><a href="/drugs/DB01211">Clarithromycin</a></td><td>The macrolide, clarithromycin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00636">Clofibrate</a></td><td>The fibrate increases the anticoagulant effect</td></tr><tr><td><a href="/drugs/DB00375">Colestipol</a></td><td>The bile acid sequestrant, colestipol, may decrease the anticoagulant effect of dicumarol by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB00531">Cyclophosphamide</a></td><td>The antineoplastic agent, cyclophosphamide may alter the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01406">Danazol</a></td><td>The androgen, danazol, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00618">Demeclocycline</a></td><td>The tetracycline, demeclocycline, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01234">Dexamethasone</a></td><td>The corticosteroid, dexamethasone, alters the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00647">Dextropropoxyphene</a></td><td>Propoxyphene may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00509">Dextrothyroxine</a></td><td>The thyroid hormone, dextrothyroxine, increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00586">Diclofenac</a></td><td>The NSAID, diclofenac, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00485">Dicloxacillin</a></td><td>Dicloxacillin may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00861">Diflunisal</a></td><td>The NSAID, diflunisal, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00822">Disulfiram</a></td><td>Disulfiram may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00254">Doxycycline</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00199">Erythromycin</a></td><td>The macrolide, erythromycin, may increase the anticoagulant effect of dicumarol..</td></tr><tr><td><a href="/drugs/DB00189">Ethchlorvynol</a></td><td>Ethchlorvynol may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>Increased thrombotic risk due to estrogen</td></tr><tr><td><a href="/drugs/DB00749">Etodolac</a></td><td>The NSAID, etodolac, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01628">Etoricoxib</a></td><td>Etoricoxib may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01039">Fenofibrate</a></td><td>Fenofibrate may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00573">Fenoprofen</a></td><td>The NSAID, fenoprofen, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00196">Fluconazole</a></td><td>Fluconazole may increase the serum concentration of dicumarol by decreasing its metabolism.</td></tr><tr><td><a href="/drugs/DB00687">Fludrocortisone</a></td><td>The corticosteroid, fludrocortisone, alters the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00544">Fluorouracil</a></td><td>The antineoplasic agent, fluorouracil, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00472">Fluoxetine</a></td><td>The SSRI, fluoxetine, increases the effect of anticoagulant, dicumarol.</td></tr><tr><td><a href="/drugs/DB01185">Fluoxymesterone</a></td><td>The androgen, fluoxymesterone, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00712">Flurbiprofen</a></td><td>The NSAID, flurbiprofen, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01095">Fluvastatin</a></td><td>Fluvastatin may increase the anticoagulant effect of dicumarol. Monitor for changes in the therapeutic and adverse effects of dicumarol if fluvastatin if initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00176">Fluvoxamine</a></td><td>Fluvoxamine may increase the anticoagulant effect of dicumarol by increasing its serum concentration.</td></tr><tr><td><a href="/drugs/DB01319">Fosamprenavir</a></td><td>The protease inhibitor, fosamprenavir, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Increased hydantoin levels and risk of bleeding</td></tr><tr><td><a href="/drugs/DB00317">Gefitinib</a></td><td>Gefitinib may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00441">Gemcitabine</a></td><td>Gemcitabine may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01241">Gemfibrozil</a></td><td>Gemfibrozil may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01120">Gliclazide</a></td><td>Dicumarol may increase the effect of sulfonylurea, gliclazide.</td></tr><tr><td><a href="/drugs/DB01437">Glutethimide</a></td><td>Glutethimide may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01016">Glyburide</a></td><td>Dicumarol may increase the effect of sulfonylurea, glibenclamide.</td></tr><tr><td><a href="/drugs/DB00400">Griseofulvin</a></td><td>Griseofulvin may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00741">Hydrocortisone</a></td><td>The corticosteroid, hydrocortisone, alters the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01050">Ibuprofen</a></td><td>The NSAID, ibuprofen, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00619">Imatinib</a></td><td>Imatinib may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00224">Indinavir</a></td><td>The protease inhibitor, indinavir, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00328">Indomethacin</a></td><td>The NSAID, indomethacin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00951">Isoniazid</a></td><td>Isoniazid may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01167">Itraconazole</a></td><td>Itraconazole may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01026">Ketoconazole</a></td><td>Ketoconazole may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01009">Ketoprofen</a></td><td>The NSAID, ketoprofen, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00465">Ketorolac</a></td><td>The NSAID, ketorolac, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01097">Leflunomide</a></td><td>Leflunomide may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00848">Levamisole</a></td><td>Levamisole may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01137">Levofloxacin</a></td><td>The quinolone antibiotic, levofloxacin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00451">Levothyroxine</a></td><td>The thyroid hormone, levothyroxine, increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00227">Lovastatin</a></td><td>Lovastatin may increase the anticoagulant effect dicumarol. Monitor for changes in the therapeutic and adverse effects of dicumarol if lovastatin is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB01283">Lumiracoxib</a></td><td>Lumiracoxib may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00603">Medroxyprogesterone Acetate</a></td><td>Medroxyprogesterone may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00784">Mefenamic acid</a></td><td>The NSAID, mefanamic acid, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00358">Mefloquine</a></td><td>Mefloquine may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00814">Meloxicam</a></td><td>Meloxicam may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01033">Mercaptopurine</a></td><td>Mercaptopurine may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00763">Methimazole</a></td><td>The antithyroid agent, methimazole, may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00916">Metronidazole</a></td><td>Metronidazole may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01110">Miconazole</a></td><td>Miconazole may increase the serum concentration of dicumarol by decreasing its metabolism.</td></tr><tr><td><a href="/drugs/DB01017">Minocycline</a></td><td>The tetracycline, minocycline, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00648">Mitotane</a></td><td>Mitotane may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00218">Moxifloxacin</a></td><td>The quinolone antibiotic, moxifloxacin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00461">Nabumetone</a></td><td>The NSAID, nabumetone, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00779">Nalidixic Acid</a></td><td>The quinolone antibiotic, nalidixic acid, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00788">Naproxen</a></td><td>The NSAID, naproxen, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00220">Nelfinavir</a></td><td>The protease inhibitor, nelfinavir, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00238">Nevirapine</a></td><td>Nevirapine may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>The quinolone antibiotic, norfloxacin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01165">Ofloxacin</a></td><td>The quinolone antibiotic, ofloxacin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01083">Orlistat</a></td><td>Orlistat may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00991">Oxaprozin</a></td><td>The NSAID, oxaprozin, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB03585">Oxyphenbutazone</a></td><td>The NSAID, oxyphenbutazone, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00715">Paroxetine</a></td><td>The SSRI, paroxetine, increases the effect of anticoagulant, dicumarol.
</td></tr><tr><td><a href="/drugs/DB00806">Pentoxifylline</a></td><td>Pentoxifylline may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The barbiturate, phenobarbital, decreases the anticoagulant effect, dicumarol.</td></tr><tr><td><a href="/drugs/DB00812">Phenylbutazone</a></td><td>The NSAID, phenylbutazone, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Increased hydantoin levels and risk of bleeding</td></tr><tr><td><a href="/drugs/DB00554">Piroxicam</a></td><td>The NSAID, piroxicam, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00860">Prednisolone</a></td><td>The corticosteroid, prednisolone, alters the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00635">Prednisone</a></td><td>The corticosteroid, prednisone, alters the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The barbiturate, primidone, decreases the anticoagulant effect, dicumarol.</td></tr><tr><td><a href="/drugs/DB01182">Propafenone</a></td><td>Propafenone may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00550">Propylthiouracil</a></td><td>The anti-thyroid agent, propylthiouracil, may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00908">Quinidine</a></td><td>Quinidine may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00468">Quinine</a></td><td>Quinine may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00863">Ranitidine</a></td><td>Ranitidine may increase the anticoagulant effect of dicumarol. (Conflicting evidence)</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>Rifabutin may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>Rifampin may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00976">Telithromycin</a></td><td>Telithromycin may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00469">Tenoxicam</a></td><td>The NSAID, tenoxicam, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00624">Testosterone</a></td><td>The androgen may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00759">Tetracycline</a></td><td>Tetracycline may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00560">Tigecycline</a></td><td>Tigecycline may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00620">Triamcinolone</a></td><td>The corticosteroid, triamcinolone, alters the anticoagulant effect of dicumarol.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>